Author: Mayank Batavia (page 1 of 6)

The 2023 Update on The National Artificial Intelligence R&D Strategic Plan by the US government provides some insights on how the government will shape its policy to regulate and leverage AI.

Prepared by the Select Committee On Artificial Intelligence of The National Science And Technology Council, the report is key to understanding how the US plans “to sustain and enhance the scientific, technological, and economic leadership position of the United States in AI.”

China’s crackdown on tech companies hasn’t really surprised anyone who knows China. However, the extent to which the Chinese authorities went has raised new questions without really answering the older ones.

In this post, we look at the backdrop to sense where the China clampdown on what were almost untouchable giants began. We look at some data and hypothesize what led to China taking what sounded like a drastic step. 

The medical applications of 3D printing technology are widening every day with an increasing number of people becoming careful about their dental health. How 3D printing can help healthcare became even more popular when people realised how 3D printing was helping fight Covid-19.

Digital dentistry is about half a century old, around 1971. It started out with computer-based analysis and slowly began offering insights to doctors for diagnosis and surgery. Today, the FDA uses Research, Regulate and Resource – known as the 3 R’s of 3D printing – to better define their role of the regulatory agency. 

Marketing automation tools have become both popular and indispensable. Because nearly all businesses use some martech or the other, there has been a huge rise in the number of such tools and services.

As a result, it becomes necessary to closely understand which of the tools suits the needs of your business the best. For instance, you want to see how they’d help you comply with the latest data privacy judgements, like the Schrems II ruling.

Let’s take a look and see how we can best compare marketing automation tools.

The Gopalakrishnan Committee, setup by the Indian government on non-Personal Data Governance Framework, submitted its draft report in July 2020.

The draft report of the committee that’s headed by chairman Kris Gopalakrishnan, co-founder Infosys proposed setting up a dedicated authority that would ensure non-personal data would be used for sovereign and commercial purposes.

The Court of Justice of the European Union (CJEU) issued its decision on a data protection that now become popular as Schrems II.

Many expert see this judgment as one that will have far-reaching impact on data privacy issues and the related challenges, particularly on how (and whether) data can be transferred out of European borders.

3D Printing is re-inventing itself by trying to meet the acute shortage of medical devices, objects and even quarantine rooms

As we sit down to write how 3D printing is fighting against Coronavirus, the officially confirmed cases of Coronovirus disease worldwide are over to 2.46 MN with over 165,000 deaths.

The European Commission (EC), on February 19 2020, released a document titled A European Strategy for Data. This document is a road-map for the member countries of the European Union (EU) in the data economy for the next five years.

Sumitomo Dainippon Pharma Co., Ltd, Japan and Exscientia Ltd., UK have announced the Phase I clinical trial of DSP-1181, a drug created using Artificial Intelligence (AI). The drug aims to treat obsessive-compulsive disorder (OCD). The trial begins in Japan from March 2020.

When you hear technology in pharmaceutical industry, what’s your first thoughts? Probably chemicals, labs and large machines.

That’s no longer the case. Some time back, Amazon and two other companies started off a healthcare startup Haven. Technology is strongly helping the pharma industry. Read more about the 5 ways pharmaceutical industry is using technology: